Repligen Corporation
RGEN
$130.13
$4.803.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 763.34M | 738.26M | 707.89M | 673.96M | 650.43M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 763.34M | 738.26M | 707.89M | 673.96M | 650.43M |
| Cost of Revenue | 357.71M | 349.54M | 342.70M | 330.31M | 317.73M |
| Gross Profit | 405.63M | 388.71M | 365.19M | 343.65M | 332.70M |
| SG&A Expenses | 293.97M | 288.14M | 274.10M | 256.98M | 247.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 707.41M | 691.06M | 668.73M | 634.75M | 609.40M |
| Operating Income | 55.93M | 47.20M | 39.16M | 39.20M | 41.03M |
| Income Before Tax | 56.21M | 62.38M | 4.66M | -13.60M | -22.79M |
| Income Tax Expenses | 4.82M | 13.49M | 2.92M | 228.00K | 193.00K |
| Earnings from Continuing Operations | 51.40 | 48.89 | 1.74 | -13.83 | -22.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.40M | 48.89M | 1.74M | -13.83M | -22.98M |
| EBIT | 55.93M | 47.20M | 39.16M | 39.20M | 41.03M |
| EBITDA | 135.74M | 125.94M | 116.32M | 113.78M | 112.49M |
| EPS Basic | 0.91 | 0.87 | 0.03 | -0.25 | -0.41 |
| Normalized Basic EPS | 0.68 | 0.60 | 0.48 | 0.55 | 0.56 |
| EPS Diluted | 0.90 | 0.85 | 0.01 | -0.26 | -0.42 |
| Normalized Diluted EPS | 0.68 | 0.60 | 0.48 | 0.55 | 0.56 |
| Average Basic Shares Outstanding | 225.16M | 224.93M | 224.68M | 224.43M | 224.08M |
| Average Diluted Shares Outstanding | 226.37M | 226.26M | 225.66M | 225.14M | 225.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |